Newsroom
HeRO™ Clinical Trial Passes another Milestone: 2,150 Patients Enrolled
Greenville Hospital System Joins HeRO™ Patient Outcomes Study
Canadian Patent Issued on HeRO™ Technology
HeRO™ Clinical Trial Achieves 1,650 Patient Enrollments
European Patent Office Grants Patent on HeRO™ Technology
Vanderbilt University Joins HeRO™ Patient Outcomes Study
New HeRO™ Data Acquisition Device Receives FDA Clearance
The Penn State University Milton S. Hershey Medical Center Joins HeRO™ Patient Outcomes Study
Winnie Palmer Hospital for Women and Babies Joins HeRO™ Patient Outcomes Study
New HeRO™ Data Acquisition Device Receives Medical Safety Approval
University of Alabama - Birmingham Joins HeRO™ Patient Outcomes Study
Wake Forest University Joins HeRO™ Patient Outcomes Study
HeRO™ Patient Outcomes Study Receives NIH Grant
HeRO™ Research Begins in Pediatric Intensive Care Unit at the University of Virginia
MPSC to Begin Outcomes Study at UVA NICU for HeRO™ Heart Rate Observation System
Medical Predictive Science Corporation Announces FDA Clearance of HeRO™ Technology
About MPSC | HeRO™ Product Information | References Cite HeRO™ | Contact Us | Legal | News | Support | Home
© 2006. HeRO is a trademark of Medical Predictive Science Corporation.
